Siemens acquires the US company Dotmatics, a leading provider of research and development software for the life sciences industry for $ 5.1 billion.
The technology group thus increases the addressable overall market for industrial software by $ 11 billion, as he announced in Munich. Seller is insight partners.
“With the acquisition of Dotmatics, we strategically strengthen our position in Life Sciences,” said Siemens CEO Roland Busch. The company based in Boston helps customers provide data for AI-based drug development.
The takeover “primarily” by selling shares to listed companies is to be financed, said CFO Ralf Thomas and in this context also named Siemens Healthineers. The Siemens share occurs by 0.09 percent to EUR 215.30 at times in the post-market tradegate trade.
Dow Jones
Selected leverage products on Siemens
With knock-outs, speculative investors can participate disproportionately in price movements. Simply choose the desired lever and we will show you suitable open-end products on Siemens
The lever must be between 2 and 20
Advertising